Malin shares rise as it buys stake in UK drugs firm

Shares in Irish life sciences and biotech investment firm, Malin Corporation, rose 4% as it bought a 33% stake in UK company, Wren Therapeutics, which is focused on drugs used to fight Alzheimer’s and Parkinson’s Disease.
Malin shares rise as it buys stake in UK drugs firm

Malin shares are listed on the Irish Stock Exchange’s Enterprise Securities Market (ESM).

Cambridge-based Wren focuses on drug discovery and clinical translation of molecules that will impact 30 protein misfolding diseases, such as Alzheimer’s and type-2 diabetes.

Wren, spun out of the University of Cambridge and Lund University, Sweden, was formally founded in 2016. Under the transaction terms, Malin has an option to increase its shareholding to 67%.

Chief executive of Malin, Kelly Martin, is a former chief executive of Elan.

Malin was formed in 2014, by former Elan executives, to invest in life science firms that see trade sales or IPOs as premature moves.

It counts the Irish Strategic Investment Fund and the UK-based Woodford Investment Management as cornerstone backers.

Last year, Malin secured €70m in debt funding from the European Investment Bank to enable the company to increase stakes in companies in which it has already invested, and to meet further acquisition opportunities.

Malin, which joined the ESM junior market last year, has carried out a number of investments in drug development and biotechnology firms in Ireland, the UK, and the US.

More in this section

Budget 2022 Logo

What impact will this  year's budget have on you and your business.

The Business Hub

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Sign up
Puzzles logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day. PS ... We would love to hear your feedback on the section right HERE.

News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up

Our Covid-free newsletter brings together some of the best bits from, as chosen by our editor, direct to your inbox every Monday.

Sign up